Sanyou Biopharmaceuticals (Shanghai) Co. Ltd. has launched its Sanyou Super Trillion Peptide Molecule Discovery Platform, suitable for the R&D of peptide-based drugs targeting diseases associated with metabolism and tumors, as well as applications in medical imaging, molecular diagnostics and other fields.